These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32781107)

  • 41. Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement.
    Gibbs RB
    Brain Res; 1998 Mar; 787(2):259-68. PubMed ID: 9518642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease.
    Savaskan E; Olivieri G; Meier F; Ravid R; Müller-Spahn F
    Brain Res; 2001 Jul; 908(2):113-9. PubMed ID: 11454321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hippocampal shape analysis in Alzheimer's disease: a population-based study.
    Scher AI; Xu Y; Korf ES; White LR; Scheltens P; Toga AW; Thompson PM; Hartley SW; Witter MP; Valentino DJ; Launer LJ
    Neuroimage; 2007 May; 36(1):8-18. PubMed ID: 17434756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
    Maki PM; Henderson VW
    Climacteric; 2012 Jun; 15(3):256-62. PubMed ID: 22612612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen therapy and cognition: a review of the cholinergic hypothesis.
    Gibbs RB
    Endocr Rev; 2010 Apr; 31(2):224-53. PubMed ID: 20019127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen, cognition, and a woman's risk of Alzheimer's disease.
    Henderson VW
    Am J Med; 1997 Sep; 103(3A):11S-18S. PubMed ID: 9344402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gender, sex steroid hormones, and Alzheimer's disease.
    Vest RS; Pike CJ
    Horm Behav; 2013 Feb; 63(2):301-7. PubMed ID: 22554955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
    J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estrogens and brain function.
    Markou A; Duka T; Prelevic GM
    Hormones (Athens); 2005; 4(1):9-17. PubMed ID: 16574627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hippocampal morphometry in population-based incident Alzheimer's disease and vascular dementia: the HAAS.
    Scher AI; Xu Y; Korf ES; Hartley SW; Witter MP; Scheltens P; White LR; Thompson PM; Toga AW; Valentino DJ; Launer LJ
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):373-6. PubMed ID: 20826877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sexual Dimorphism and Hemispheric Asymmetry of Hippocampal Volumetric Integrity in Normal Aging and Alzheimer Disease.
    Ardekani BA; Hadid SA; Blessing E; Bachman AH
    AJNR Am J Neuroradiol; 2019 Feb; 40(2):276-282. PubMed ID: 30655257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials.
    Zec RF; Trivedi MA
    Climacteric; 2002 Jun; 5(2):122-34. PubMed ID: 12051107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can estrogen play a significant role in the prevention of Alzheimer's disease?
    Kesslak JP
    J Neural Transm Suppl; 2002; (62):227-39. PubMed ID: 12456066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced presynaptic vesicle stores mediate cellular and network plasticity defects in an early-stage mouse model of Alzheimer's disease.
    Chakroborty S; Hill ES; Christian DT; Helfrich R; Riley S; Schneider C; Kapecki N; Mustaly-Kalimi S; Seiler FA; Peterson DA; West AR; Vertel BM; Frost WN; Stutzmann GE
    Mol Neurodegener; 2019 Jan; 14(1):7. PubMed ID: 30670054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exercise counteracts declining hippocampal function in aging and Alzheimer's disease.
    Intlekofer KA; Cotman CW
    Neurobiol Dis; 2013 Sep; 57():47-55. PubMed ID: 22750524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female mice.
    Palm R; Chang J; Blair J; Garcia-Mesa Y; Lee HG; Castellani RJ; Smith MA; Zhu X; Casadesus G
    J Neurochem; 2014 Jul; 130(1):115-25. PubMed ID: 24601954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
    Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Steroids, cognitive processes and aging].
    Müller EE
    Recenti Prog Med; 2001 May; 92(5):362-72. PubMed ID: 11413897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combining viscoelasticity, diffusivity and volume of the hippocampus for the diagnosis of Alzheimer's disease based on magnetic resonance imaging.
    Gerischer LM; Fehlner A; Köbe T; Prehn K; Antonenko D; Grittner U; Braun J; Sack I; Flöel A
    Neuroimage Clin; 2018; 18():485-493. PubMed ID: 29527504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.